Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2014 participants
OBSERVATIONAL
2009-11-30
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Attain Success Lead
Attain Success Lead
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject will be implanted with Medtronic cardiac resynchronization therapy (CRT) device and Medtronic left heart lead utilizing (or attempting to utilize) Attain Family of delivery catheters. The implant procedure may include upgrades to CRT from implantable pulse generator (IPG) or implantable cardioverter-defibrillator (ICD).
Exclusion Criteria
* Subject has existing CRT system implanted or was previously implanted with a CRT system.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John D Hummel, MD
Role: PRINCIPAL_INVESTIGATOR
Davis Heart & Lung Research Institute, The Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Little Rock, Arkansas, United States
Downey, California, United States
Modesto, California, United States
Redding, California, United States
Riverside, California, United States
San Diego, California, United States
San Jose, California, United States
Santa Rosa, California, United States
Danbury, Connecticut, United States
Washington D.C., District of Columbia, United States
Delray Beach, Florida, United States
Lake Mary, Florida, United States
Naples, Florida, United States
Orlando, Florida, United States
Panama City, Florida, United States
Saint Augustine, Florida, United States
Tampa, Florida, United States
Athens, Georgia, United States
Atlanta, Georgia, United States
Macon, Georgia, United States
Marietta, Georgia, United States
Chicago, Illinois, United States
Decatur, Illinois, United States
Indianapolis, Indiana, United States
Newburgh, Indiana, United States
Overland Park, Kansas, United States
Bowling Green, Kentucky, United States
Lexington, Kentucky, United States
Houma, Louisiana, United States
Baltimore, Maryland, United States
Takoma Park, Maryland, United States
Boston, Massachusetts, United States
Muskegon, Michigan, United States
Royal Oak, Michigan, United States
Saint Clair Shore, Michigan, United States
Ypsilanti, Michigan, United States
Minneapolis, Minnesota, United States
St Louis, Missouri, United States
Washington, Missouri, United States
Omaha, Nebraska, United States
Concord, New Hampshire, United States
Englewood, New Jersey, United States
Huntington, New York, United States
Asheville, North Carolina, United States
Concord, North Carolina, United States
Fargo, North Dakota, United States
Cleveland, Ohio, United States
Columbus, Ohio, United States
Kettering, Ohio, United States
Abington, Pennsylvania, United States
Bethlehem, Pennsylvania, United States
Erie, Pennsylvania, United States
Harrisburg, Pennsylvania, United States
Wormleysburg, Pennsylvania, United States
Florence, South Carolina, United States
Germantown, Tennessee, United States
Knoxsville, Tennessee, United States
Nashville, Tennessee, United States
Amarillo, Texas, United States
Austin, Texas, United States
Brownsville, Texas, United States
Dallas, Texas, United States
Fort Worth, Texas, United States
Houston, Texas, United States
Longview, Texas, United States
The Woodlands, Texas, United States
Murray, Utah, United States
Salt Lake City, Utah, United States
Frederickburg, Virginia, United States
Bellingham, Washington, United States
Spokane, Washington, United States
Green Bay, Wisconsin, United States
Ontario, , Canada
Jiangsu, , China
Sichuan, , China
Xinjian, , China
Amiens, , France
Anglouleme, , France
Bayonne, , France
Bordeaux, , France
Clermont-Ferrand, , France
Créteil, , France
Metz-Tessy, , France
Montfermeil, , France
Nice, , France
Orléans, , France
Paris, , France
Poitiers, , France
Villingen, , Germany
Shatin, , Hong Kong
Haryāna, , India
New Dehli, , India
New Delhi, , India
Rajasthan, , India
Vizag, , India
Kuala Lumpur, , Malaysia
Tal-Qroqq, , Malta
Lahore, , Pakistan
Bydgoszcz, , Poland
Krakow, , Poland
Zabreze, , Poland
San Juan, , Puerto Rico
Brasov, , Romania
Bucharest, , Romania
Novena, , Singapore
Taichung, , Taiwan
Taipei, , Taiwan
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Attain Success
Identifier Type: -
Identifier Source: org_study_id